Overview

Study of the Safety and Efficacy of Long-Term Rilonacept Treatment for the Prevention of Gout Flares

Status:
Terminated
Trial end date:
2013-06-01
Target enrollment:
Participant gender:
Summary
The purpose of this study was to determine the safety and tolerability of rilonacept for participants with gout who were initiating allopurinol.
Phase:
Phase 3
Details
Lead Sponsor:
Regeneron Pharmaceuticals
Treatments:
Allopurinol
Rilonacept